Skip to content
HowShorted

Xponential Fitness, Inc. short interest in 2024

In 2024, Xponential Fitness, Inc.'s disclosed short interest ran from 5.55% of shares outstanding on 12 Jan 2024 to 19.12% on 31 Dec 2024, a change of +13.57 percentage points. The year's high was 29.67% on 13 Sep 2024 and its low 4.97% on 28 Mar 2024, averaging 19.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.65 days on 15 Oct 2024. Full history: Xponential Fitness, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Xponential Fitness, Inc. in 2024

2024 in figures

Start of year
5.55% (12 Jan 2024)
End of year
19.12% (31 Dec 2024)
Change
+13.57 pp
High
29.67% (13 Sep 2024)
Low
4.97% (28 Mar 2024)
Average
19.28%
Highest days to cover
16.65 (15 Oct 2024)
SEC filings marked
9

Every report in 2024

Xponential Fitness, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 20245.55%3.44results (8-K)
31 Jan 20245.99%9.63
15 Feb 20245.85%6.24
29 Feb 20246.34%3.97results (8-K)
15 Mar 20245.00%1.7210-K filed
28 Mar 20244.97%4.54
15 Apr 20246.97%6.67
30 Apr 202424.07%5.79
15 May 202426.56%2.77results (8-K), 10-Q filed
31 May 202423.76%4.53
14 Jun 202423.72%5.81
28 Jun 202421.88%3.10
15 Jul 202424.27%7.47
31 Jul 202425.79%7.09
15 Aug 202429.09%4.43results (8-K), 10-Q filed
30 Aug 202428.63%14.53
13 Sep 202429.67%9.51
30 Sep 202428.55%14.92
15 Oct 202426.86%16.65
31 Oct 202426.12%16.23
15 Nov 202424.48%5.25results (8-K), 10-Q filed
29 Nov 202420.49%4.58
13 Dec 202418.94%8.66
31 Dec 202419.12%7.84

See also: Xponential Fitness, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.